Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient (CHIC)

October 22, 2018 updated by: Assistance Publique - Hôpitaux de Paris

Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient.

Evaluate the benefit of systematic appointment with a cardiologist a week after hospitalisation for acute heart failure. Randomised, endpoint: number of day alive out of hospital during 6 months

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background: the risk for rehospitalisation is very high after hospitalisation for acute heart failure. Aim: evaluate the benefit of a consultation with a cardiologist, including echocardiography and education of the patient, between 7 and 15 days after discharge, in high risk patients, identified with BNP or incomplete therapy. Parallel randomised study. The main endpoint is the number of day alive out of hospital during the 6 months post discharge; statistics intention to treat comparison of the number of days alive out of hospital in the group with consultation compared with the group without consultation. Recruitment 3 years and 4 months, follow-up 6 months. Patients included have been hospitalised in hospital BICHAT 75018 Paris, France. Financing is by the ministry of health (PHRQHOS)

Study Type

Interventional

Enrollment (Actual)

326

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75018
        • Hôpital Bichat Claude Bernard

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Criteria of inclusion :

  • Patient with decompensated heart failure hospitalized in the hospital BICHAT,
  • For whom is planned a return at home,
  • Valid (being able to return for a consultation to the hospital)
  • Having Nt-ProBNP of exit ≥ 3500 ng /l and/or a non optimized treatment of exit - according to the doctor who has it the responsibility,
  • Having signed the consent form by participation in the study.

Criteria of not inclusion :

  • Age < 18 years,
  • Not membership in a national insurance scheme or in the Universal Health
  • Coverage (CMU)(FREE UNIVERSAL HEALTH CARE)(A patient benefiting from the Medical aid of the State (AME) cannot be included)
  • Participation to another protocol of research,
  • Not being reachable by telephone in 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
usual care without systematic cardiology evaluation between 1 and 2 weeks
Experimental: Follow-up
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary
Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
days alive out of hospital 6 months post discharge
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
rehospitalisation rate at 6 months
Time Frame: 6 months
6 months
mortality at 3 and 6 months
Time Frame: 3 and 6 months
3 and 6 months
number of patients receiving beta-blocker at 6 months
Time Frame: 6 months
6 months
number of patients receiving a ACEI at 6 months
Time Frame: 6 months
6 months
QOL at 6 months
Time Frame: 6 months
6 months
autoevaluation of improvement/alteration of the patient state at 6 months
Time Frame: 6 months
6 months
number of patients receiving beta-blocker at 3 months
Time Frame: 3 months
3 months
number of patients receiving a ACEI at 3 months
Time Frame: 3 months
3 months
QOL at 3 months
Time Frame: 3 months
3 months
autoevaluation of improvement/alteration of the patient state at 3 months
Time Frame: 3 months
3 months
number of patients having an optimal treatment at 6 months
Time Frame: 6 months
6 months
number of patients having an optimal treatment at 3 months
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Guillaume JONDEAU, MD, PHD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2013

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

July 1, 2017

Study Registration Dates

First Submitted

January 17, 2013

First Submitted That Met QC Criteria

April 17, 2013

First Posted (Estimate)

April 18, 2013

Study Record Updates

Last Update Posted (Actual)

October 23, 2018

Last Update Submitted That Met QC Criteria

October 22, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P110601 - PHRQ1104

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Heart Failure

Clinical Trials on Follow-up

3
Subscribe